Skip to main content
Log in

Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients

  • ORIGINAL PAPER
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Many theories have been put forward to explain the mechanism of stone formation and growth. The aim of this study was to investigate the urinary, serum and stone levels of zinc, iron, magnesium, and copper in patients with calcium oxalate stones and to investigate urinary and serum element levels in healthy controls and to find a possible connection between the elements and calcium oxalate stone formation. A total of 104 patients with calcium oxalate stones ranging in age from 3 to 79 years (mean 44.0 ± 18.1) and 77 healthy controls ranging in age from 18 to 77 (mean 44.2 ± 17.9) were included in this study. The mean urinary iron and copper levels in stone patients were significantly higher than healthy controls (P = 0.000). The mean urinary zinc and magnesium levels in healthy controls were significantly higher than stone patients (P = 0.000). There was no significant difference in the serum levels of magnesium and copper in stone patients and healthy controls. Serum zinc and iron level were significantly high in healthy controls as compared to stone patients. Each stone had all 4 elements. Zn and Mg have inhibitory effect on calcium oxalate stone formation. Fe and Cu could be promotor of the calcium oxalate stone formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rangnekar GV, Gaur MS (1993) Serum and urinary zinc levels in urolithiasis. Br J Urol 71:527–529

    PubMed  CAS  Google Scholar 

  2. Fleisch H (1978) Inhibitors and promoters of stone formation. Kidney Int 13:361

    Article  PubMed  CAS  Google Scholar 

  3. Joost J, Tessadri R (1987) Trace element investigations in kidney stone patients. Eur Urol 13:264–270

    PubMed  CAS  Google Scholar 

  4. Thomas WE, Bird ED, Tomita A (1963) Some concepts concerning the genesis of urinary calculi. Invest Urol 90:521–526

    Google Scholar 

  5. Meyer JL, Angino EE (1977) The role of trace metals in calcium urolithiasis. Invest Urol 14:347–350

    PubMed  CAS  Google Scholar 

  6. Trinchieri A, Mandressi A, Luongo P, Longo G, Pisani E (1991) The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol 67:230–236

    PubMed  CAS  Google Scholar 

  7. Komleh K, Hada P, Pendse AK, Singh PP (1990) Zinc, copper and manganase in serum, urine, and stones. Int Urol Nephrol 22:113–118

    Article  PubMed  CAS  Google Scholar 

  8. Ozgurtas T, Yakut G, Gulec M, Serdar M, Kutluay T (2004) Role of urinary zinc and copper on calcium oxalate stone formation. Urol Int 72:233–236

    Article  PubMed  CAS  Google Scholar 

  9. Kumar S, Gupta A, Shrivastava DK (1984) Role of zinc in nephrolithiasis. J Indian Med Assoc 82:235–237

    PubMed  Google Scholar 

  10. Francois B, Cahen R, Pascal B (1986) Inhibitors of urinary stone formation in 40 recurrent stone formers. Br J Urol 58:479–483

    PubMed  CAS  Google Scholar 

  11. Anke M, Schneider HJ (1973) Die bedeutung der spurenelemente in der pathogenese and Therapie der urolithiasis. III. Jenaer Harnsteinsymposium, pp 116–126

  12. Elliot JS, Ribeiro ME (1973) The urinary excretion of trace metals in patients with calcium oxalate urinary stone. Invest Urol 10:253–255

    Article  PubMed  CAS  Google Scholar 

  13. Hofbauer J, Steffan I, Hobarth K, Vujicic G, Schwetz H, Reich G, Zechner O (1991) Trace elements and urinary stone formation: new aspects of the pathological mechanism of urinary stone formation. J Urol 145:93–96

    PubMed  CAS  Google Scholar 

  14. Welshman SG, Mcgeown MG (1972) A quantitative investigation of the effects on the growth of calcium oxalate crystals on potential inhibitors. Br J Urol 44:677–680

    Article  PubMed  CAS  Google Scholar 

  15. Cohanim M, Yendt ER (1975) The effects of thiazides on serum and urinary zinc in patients with renal calculi. Johns Hopkins Med J 136:137–141

    PubMed  CAS  Google Scholar 

  16. Kohri K, Garside J, Blacklock NJ (1988) The role of magnesium in calcium oxalate urolithiasis. Br J Urol 61:107–112

    PubMed  CAS  Google Scholar 

  17. Li MK, Blacklock NJ, Garside J (1985) Effects of magnesium on calcium oxalate crystallization. J Urol 133:123–128

    PubMed  CAS  Google Scholar 

  18. Borden TA, Lyon ES (1969) The effects of magnesium on pH on experimental calcium oxalate disease. Invest Urol 6:412–420

    PubMed  CAS  Google Scholar 

  19. Fragalla FF, Gershoff SN (1963) Interrelations among magnesium, vitamin B6, sulfur or phosphorus in the formation of kidney stones in the rat. J Nutr 81:60–72

    Google Scholar 

  20. Rattan V, Thind SK, Jethi RK, Sidhu H, Nath R (1993) Oxalate metabolism in magnesium-deficient rats. Magnesium Res 6:127–133

    CAS  Google Scholar 

  21. Rushton HG, Spector M (1982) Effect of magnesium deficiency in intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol 127:598–603

    PubMed  CAS  Google Scholar 

  22. Wu N, Thon WF, Krah H, Schlick R, Jonas U (1984) Effects of magnesium citrate and phytin on reducing urinary calcium excretion in rats. World J Urol 12:323–329

    Google Scholar 

  23. Esen T, Akinci M, Tellaloglu S, Kocak T (1991) Role of inhibitor deficiency in urolithiasis II: deficiency grade-adjusted and intermitent augmentation therapy for magnesium and citrate deficiency. Eur Urol 19:244–248

    PubMed  CAS  Google Scholar 

  24. Johansson G, Backman U, Danielson BG, Fellstrom B, Ljunghall S, Wikstrom B (1980) Biochemical and clinical effects of prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124:770–774

    PubMed  CAS  Google Scholar 

  25. Schmiedl A, Schwille PO (1996) Magnesium status in idiopathic calcium urolithiasis – an orientational study in younger males. Eur J Clin Chem Clin Biochem 34:393–400

    PubMed  Google Scholar 

  26. Bird ED, Thomas WC (1963) Effect of various metals on mineralization in vitro. Proc Soc Exp Biol Med 112:640

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa Kaplan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atakan, I.H., Kaplan, M., Seren, G. et al. Serum, urinary and stone zinc, iron, magnesium and copper levels in idiopathic calcium oxalate stone patients. Int Urol Nephrol 39, 351–356 (2007). https://doi.org/10.1007/s11255-006-9050-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-9050-4

Keywords

Navigation